Skip to main content
ACIU
NASDAQ Life Sciences

AC Immune Posts 13-Cent Quarterly Loss, Cash Runs Into 2028

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$2.16
Mkt Cap
$212.707M
52W Low
$2.015
52W High
$3.9
52W Position info
7.2% above low
Off High info
45% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ACIU is trading near its 52-week low of $2.015 (7.2% above the low).

Summary

AC Immune reported a third-quarter loss of 13 cents per share on revenue of $3.24 million. The company ended the quarter with CHF 73.9 million in cash, which management says funds operations into the first quarter of 2028. For a clinical-stage biotech with a roughly $213 million market cap, that runway statement is the number that matters — it removes near-term financing risk while the pipeline reads out. The loss itself is routine for a company with no product revenue. The setup follows a strong stretch of data: FDA Fast Track and IND clearance for the Parkinson's immunotherapy ACI-7104 in August, positive Phase 1 data for oral NLRP3 inhibitor ACI-19764, and positive Part 1 Phase 2 results for ACI-7104 in September. Cash burn and pipeline spend are the items to track against that 2028 runway.

At the time of this announcement, ACIU was trading at $2.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $212.7M. The 52-week trading range was $2.02 to $3.90. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ACIU - Latest Insights

ACIU
Nov 04, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.16
Real-time Price: $2.11 info
Change: -$0.050 (-2%) info
Market Cap: $214.742M info
ACIU
Sep 23, 2026, 7:01 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.73
Real-time Price: $2.11 info
Change: -$0.620 (-23%) info
Market Cap: $214.742M info
ACIU
Sep 23, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.73
Real-time Price: $2.11 info
Change: -$0.620 (-23%) info
Market Cap: $214.742M info
ACIU
Aug 20, 2026, 12:32 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $2.53
Real-time Price: $2.11 info
Change: -$0.415 (-16%) info
Market Cap: $214.742M info
ACIU
Aug 20, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.64
Real-time Price: $2.11 info
Change: -$0.530 (-20%) info
Market Cap: $214.742M info